Vaccinex, Inc. (VCNX) Starts Presentation at LD Micro Main Event
Vaccinex (NASDAQ: VCNX) is a clinical-stage immunotherapy company engaged in discovering and developing targeted biotherapeutics. The company’s biotherapeutics are targeted to treat serious diseases and conditions with unmet medical needs including cancer, neurodegenerative diseases, and autoimmune disorders. Currently, Vaccinex has active clinical trials in non-small cell lung cancer and Huntington’s disease. For more information, visit the company’s website at www.Vaccinex.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial…







